Boston, Massachusetts, United States Partners HealthCare is the famous Corporate Investor, which was founded in 1994. The main office of represented Corporate Investor is situated in the Boston. The company was established in North America in United States.
Speaking about the real fund results, this Corporate Investor is 9 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2016. Opposing the other organizations, this Partners HealthCare works on 7 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the various public portfolio startups of the fund, we may underline Lyndra Therapeutics, GlobeImmune, Provasculon Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Hospital.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Partners HealthCare, startups are often financed by Polaris Partners, Flybridge Capital Partners, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Flybridge Capital Partners, Flagship Pioneering. In the next rounds fund is usually obtained by Polaris Partners, WS Investments, Physic Ventures.
We also calculated 11 valuable employees in our database.
Related Funds
| Fund Name | Location |
| Amicle Capital | - |
| AVICT Global Holdings | - |
| Chuangying Keji (Dalian) Zhongxin (Youxian Hehuo) | China, Dalian Shi, Liaoning |
| Countersoft | England, London, United Kingdom |
| Dashang Group | China, Dalian Shi, Liaoning |
| Engineering Capital | California, Palo Alto, United States |
| Enhanced Capital Partners | New York, New York, United States |
| FinSight Ventures | California, Palo Alto, United States |
| Goldacre | England, London, United Kingdom |
| Green Meadow Ventures | Menomonee Falls, United States, Wisconsin |
| Illuminate Ventures | California, Oakland, United States |
| Indogen Capital | Indonesia, Jakarta, Jakarta Raya |
| Kwai Hung Group | - |
| Massachusetts Green Energy Fund | Brookline, Massachusetts, United States |
| MYSTIC Entertainment | - |
| Octopus Labs | England, London, United Kingdom |
| Venture Angels | - |
| WAVE Equity Partners | Boston, Massachusetts, United States |
| Yu Holdings | China, Shanghai |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lyndra Therapeutics | $60M | 11 Feb 2019 | Watertown, Massachusetts, United States | ||
Lyndra Therapeutics | $23M | 13 Apr 2017 | Watertown, Massachusetts, United States | ||
T2 Biosystems | $15M | 26 May 2010 | Massachusetts, United States | ||
T2 Biosystems | $10M | 17 Oct 2008 | Massachusetts, United States | ||
| $6M | 24 Mar 2008 | Cambridge, Massachusetts, United States | |||
Freedom2 | $1M | 28 Mar 2007 | New Jersey, United States | ||
GlobeImmune | $34M | 16 Dec 2005 | Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lyndra Therapeutics | $60M | 11 Feb 2019 | Watertown, Massachusetts, United States | ||
Lyndra Therapeutics | $23M | 13 Apr 2017 | Watertown, Massachusetts, United States | ||
T2 Biosystems | $15M | 26 May 2010 | Massachusetts, United States | ||
T2 Biosystems | $10M | 17 Oct 2008 | Massachusetts, United States | ||
| $6M | 24 Mar 2008 | Cambridge, Massachusetts, United States | |||
Freedom2 | $1M | 28 Mar 2007 | New Jersey, United States | ||
GlobeImmune | $34M | 16 Dec 2005 | Colorado, United States |
